InvestorsHub Logo
Followers 42
Posts 5093
Boards Moderated 0
Alias Born 05/10/2012

Re: tdeck post# 1408

Monday, 04/15/2019 11:46:28 AM

Monday, April 15, 2019 11:46:28 AM

Post# of 7492
I have a good friend that used to run the emerging business unit for Shire pharmaceuticals. I defer to him usually because he knows how things are run inside a large pharmaceutical company... That is where the Novartis idea came from, originally tossed around by me. Same person thought ReCell would be a major benefit to Novartis because their regenerative medicine portfolio isn't very strong.

Generally, for an SVP to start dividing his time, there needs to be a purpose or at least a potential benefit for the company they really work for. In this case, Novartis. Maybe it'll happen maybe it won't but it's a reasonable conclusion.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RCEL News